Press release
Cancer Vaccines Market Growth Projections 2024-2034: DelveInsight Analysis | Dendreon Pharma, Candel Therapeutics, GlaxoSmithKline, Merck, Aduro Biotech, Astrazeneca Plc, Dendreon, Astellas Pharma
DelveInsight's "Cancer Vaccines Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Cancer Vaccines, historical and forecasted epidemiology as well as the Cancer Vaccines market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Cancer Vaccines market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Cancer Vaccines Market Forecast [https://www.delveinsight.com/sample-request/cancer-vaccines-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Some of the key facts of the Cancer Vaccines Market Report:
*
The Cancer Vaccines market size is anticipated to grow with a significant CAGR during the study period (2020-2034)
*
In March 2025, Everest Medicines has administered the first dose of EVM16, its personalized mRNA cancer vaccine, to a participant in the first-in-human (FIH) trial, EVM16CX01.
*
In February 2025, In a Phase I investigator-led trial, all nine patients who received a personalized kidney cancer vaccine developed anti-cancer immune responses after undergoing tumor removal surgery. Researchers at the Dana-Farber Cancer Institute in the U.S. administered the NeoVax personalized cancer vaccine to patients with stage III or IV clear cell renal cell carcinoma (ccRCC) following their surgeries.
*
In August 2024, BioNTech has launched global clinical trials for BNT116, an mRNA vaccine being developed as a potential treatment for non-small cell lung cancer (NSCLC). The vaccine utilizes the same mRNA technology that played a crucial role in the development of Covid-19 vaccines.
*
In February 2024, A cancer vaccine trial initiated by Moderna commences in the UK, with researchers optimistic about ushering in a new era of treatments.
*
In 2023, the estimated number of incident cases of non-small cell lung cancer (NSCLC) in the US was approximately 200,000.
*
Uveal melanoma impacts approximately 500 to 600 individuals annually in the UK.
*
The cancer vaccines market features a robust and expanding pipeline with candidates such as IO102-IO103 (IO Biotech), CAN-2409 (Candel Therapeutics), mRNA-4157 (V940) combined with KEYTRUDA (Merck and Moderna), PDClung01 (PDCline Pharma/LG Chem), and LB-LR1109 (LG Chem and AVEO Oncology). These vaccines target a variety of cancers, including non-small cell lung cancer (NSCLC), colorectal cancer, glioblastoma, melanoma, breast cancer, and more.
*
Key Cancer Vaccines Companies: Dendreon Pharma, Candel Therapeutics, GlaxoSmithKline, Merck, Aduro Biotech, Astrazeneca Plc, Dendreon, Astellas Pharma Inc, Sanofi, , Sanpower Group and CSL Ltd., Northwest Biotherapeutics, IO Biotech, Immunomic Therapeutics, Evaxion Biotech, Candel Therapeutics, Aston Sci, Evaxion Biotech, and others
*
Key Cancer Vaccines Therapies: DCVax-L, IO102-IO103, ITI-1000, EVX-01, CAN-2409, AST-301, EVX-02, and others
*
Several vaccine constructions have been tested for anticancer therapy. In each case, these vaccines are designed to present tumor-associated peptides integrated with MHC molecules to cognate receptors on B or T lymphocytes and stimulate their activation, maturation, and proliferation
*
The Cancer Vaccines market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Cancer Vaccines pipeline products will significantly revolutionize the Cancer Vaccines market dynamics.
Cancer Vaccines Overview
Cancer vaccines are a type of immunotherapy designed to stimulate the body's immune system to recognize and attack cancer cells. Unlike traditional vaccines, which prevent infectious diseases by priming the immune system to recognize and fight off specific pathogens (such as viruses or bacteria), cancer vaccines are used to treat existing cancer or to prevent cancer recurrence.
Get a Free sample for the Cancer Vaccines Market Report:
https://www.delveinsight.com/report-store/cancer-vaccines-market [https://www.delveinsight.com/report-store/cancer-vaccines-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Cancer Vaccines Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Cancer Vaccines Epidemiology Segmentation:
The Cancer Vaccines market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
*
Total Prevalence of Cancer Vaccines
*
Prevalent Cases of Cancer Vaccines by severity
*
Gender-specific Prevalence of Cancer Vaccines
*
Diagnosed Cases of Episodic and Chronic Cancer Vaccines
Download the report to understand which factors are driving Cancer Vaccines epidemiology trends @ Cancer Vaccines Epidemiology Forecast [https://www.delveinsight.com/sample-request/cancer-vaccines-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Cancer Vaccines Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Cancer Vaccines market or expected to get launched during the study period. The analysis covers Cancer Vaccines market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Cancer Vaccines Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Cancer Vaccines Therapies and Key Companies
*
PROVENGE (sipuleucel-T): Dendreon Pharmaceuticals
*
CAN-2409: Candel Therapeutics
*
LB-LR1109: LG Chem and AVEO Oncology
*
DCVax-L: Northwest Biotherapeutics
*
IO102-IO103: IO Biotech
*
ITI-1000: Immunomic Therapeutics
*
EVX-01: Evaxion Biotech
*
CAN-2409: Candel Therapeutics
*
AST-301: Aston Sci
*
EVX-02: Evaxion Biotech
Discover more about therapies set to grab major Cancer Vaccines market share @ Cancer Vaccines Treatment Market [https://www.delveinsight.com/sample-request/cancer-vaccines-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Cancer Vaccines Market Strengths
*
Advancements in computational and bioinformatics platforms and several other R&D practices enable the development of cancer neoantigen vaccination strategies
*
Neoantigen-based Personalized Cancer Therapeutic Vaccines like Vigil and Tedopi along with few others can stimulate immune responses to checkpoint inhibitors even in patients that have previously failed conventional treatment regimes, thereby, addressing potential unmet needs of the market
Cancer Vaccines Market Opportunities
*
Rising incidence of cancer will provide a larger window of opportunity for these novel vaccines
*
Recurrence is very common in cancers even after proper treatment. This opens up new window for Neoantigen-based Personalized Cancer Therapeutic Vaccines to dominate the treatment regime
Scope of the Cancer Vaccines Market Report
*
Study Period: 2020-2034
*
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
*
Key Cancer Vaccines Companies: Dendreon Pharma, Candel Therapeutics, GlaxoSmithKline, Merck, Aduro Biotech, Astrazeneca Plc, Dendreon, Astellas Pharma Inc, Sanofi, Sanpower Group and CSL Ltd., Northwest Biotherapeutics, IO Biotech, Immunomic Therapeutics, Evaxion Biotech, Candel Therapeutics, Aston Sci, Evaxion Biotech, and others
*
Key Cancer Vaccines Therapies: DCVax-L, IO102-IO103, ITI-1000, EVX-01, CAN-2409, AST-301, EVX-02, and others
*
Cancer Vaccines Therapeutic Assessment: Cancer Vaccines current marketed and Cancer Vaccines emerging therapies
*
Cancer Vaccines Market Dynamics: Cancer Vaccines market drivers and Cancer Vaccines market barriers
*
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
*
Cancer Vaccines Unmet Needs, KOL's views, Analyst's views, Cancer Vaccines Market Access and Reimbursement
To know more about Cancer Vaccines companies working in the treatment market, visit @ Cancer Vaccines Clinical Trials and Therapeutic Assessment [https://www.delveinsight.com/sample-request/cancer-vaccines-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Table of Contents
1. Cancer Vaccines Market Report Introduction
2. Executive Summary for Cancer Vaccines
3. SWOT analysis of Cancer Vaccines
4. Cancer Vaccines Patient Share (%) Overview at a Glance
5. Cancer Vaccines Market Overview at a Glance
6. Cancer Vaccines Disease Background and Overview
7. Cancer Vaccines Epidemiology and Patient Population
8. Country-Specific Patient Population of Cancer Vaccines
9. Cancer Vaccines Current Treatment and Medical Practices
10. Cancer Vaccines Unmet Needs
11. Cancer Vaccines Emerging Therapies
12. Cancer Vaccines Market Outlook
13. Country-Wise Cancer Vaccines Market Analysis (2020-2034)
14. Cancer Vaccines Market Access and Reimbursement of Therapies
15. Cancer Vaccines Market Drivers
16. Cancer Vaccines Market Barriers
17. Cancer Vaccines Appendix
18. Cancer Vaccines Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=cancer-vaccines-market-growth-projections-20242034-delveinsight-analysis-dendreon-pharma-candel-therapeutics-glaxosmithkline-merck-aduro-biotech-astrazeneca-plc-dendreon-astellas-pharma]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Vaccines Market Growth Projections 2024-2034: DelveInsight Analysis | Dendreon Pharma, Candel Therapeutics, GlaxoSmithKline, Merck, Aduro Biotech, Astrazeneca Plc, Dendreon, Astellas Pharma here
News-ID: 3947656 • Views: …
More Releases from ABNewswire
Best Option Restoration Strengthens South Charlotte Commitment with Local Hiring …
The demand for professional water damage cleanup South Charlotte has seen a consistent increase, driven by factors ranging from seasonal storms to aging infrastructure. This local hiring initiative allows Best Option Restoration of South Charlotte to meet this growing need more effectively. New team members, who are familiar with the specific neighborhoods and common architectural styles of the South Charlotte area, can be dispatched more rapidly.
In a significant move that…
Beyond the Flood: Best Option Restoration Brings Integrated Mold Remediation to …
For homeowners in the region searching for water damage repair near me, the integration of mold remediation is a significant benefit. It means that the company responsible for the initial drying is also accountable for preventing its most common and dangerous consequence. This seamless integration eliminates the need for a homeowner to coordinate with a separate mold mitigation company, ensuring a continuous and comprehensive recovery process.
In the critical aftermath of…
Best Option Restoration Expands Service Area to Offer 24/7 Water Damage Restorat …
The core offering now available to the Fort Mill community is a comprehensive water damage restoration service. This is a multi-stage process that begins the moment a call is placed. Certified technicians arrive promptly to conduct a thorough assessment using advanced moisture detection equipment. This initial step is crucial for identifying the full extent of the damage, including moisture hidden behind walls or under flooring.
In a strategic move to serve…
Is Couples Therapy Right? Signs It's Time to See a Counsellor in Birmingham
Relationships can be both fulfilling and challenging. No matter how strong a couple may seem on the outside, it's natural to face hurdles along the way. Miscommunication, stress, life changes, or unresolved issues can create distance between partners. While every couple goes through ups and downs, knowing when to seek professional support can make all the difference. If you've ever found yourself searching for "couples therapy near me" or wondering…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
